Methods of reducing inflammation and mucus hypersecretion
US8501911B2 · kind B2 · utility
4Cited by
15References
31Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 6, 2007 |
| Grant date | Aug 6, 2013 |
| Priority date | — |
| Expiry date | Apr 25, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/127
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compounds for decreasing MARCKS-related inflammation and MARCKS-related mucus hypersecretion or decreasing MARCKS-related inflammation in a subject by the administration of a N-terminal myristoylated protein fragment of the N-terminal region of MARCKS protein or a peptide fragment thereof are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.